Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
Third ventricular enlargement in early stages of multiple sclerosis is a predictor of motor and neuropsychological deficits: a cross-sectional study.
[Familial amyloidotic polyneuropathies].
Current and Future Therapies for Multiple Sclerosis.
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.
Spinal segmental myoclonus as an unusual presentation of multiple sclerosis.
Causes of death among persons with multiple sclerosis.
Efficacy of rituximab in refractory neuromyelitis optica.
Callosal anatomical and effective connectivity between primary motor cortices predicts visually cued bimanual temporal coordination performance.
Measuring the Impact of Multiple Sclerosis: Enhancing the Performance of the Msis-29 and Msws-12.
Pangaea 2.0: State Of The Art Multiple Sclerosis Patient Management In Daily Clinical Practice. A New 3-Year Observational Study Of Patients Receiving Fingolimod.
Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica.
Regulatory genomic regions active in immune cell types explain a large proportion of the genetic risk of multiple sclerosis.
Efficacy of gabapentin in the treatment of SUNCT syndrome.
A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.
Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats.
Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.
Body Mass Index in Multiple Sclerosis: Associations with CSF Neurotransmitter Metabolite Levels.
Contrast enhanced MR venography with gadofosveset trisodium: Evaluation of the intracranial and extracranial venous system.
Sodium Correction Practice and Clinical Outcomes in Profound Hyponatremia.
Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model.
Tablet-based screening improves continence management in multiple sclerosis.
[Efficacy and safety of natalizumab in multiple sclerosis: data from the first five years of TOP (Tysabri Observational Program) study].
Editorial: Glial Cells: Managers of Neuro-Immunity.
Role of Subventricular Zone Derived Neural Precursor Cells in the Therapy of Experimental Autoimmune Encephalomyelitis.
Pages
« first
‹ previous
…
662
663
664
665
666
667
668
669
670
…
next ›
last »